Anthem-Cigna Merger Squabbles Could Delay Antitrust Approval: WSJ
Quarrels have broken out behind the scenes of Anthem Inc.'s (ANTM.N) proposed acquisition of Cigna Corp (CI.N), as the health insurers seek regulatory approval for their landmark deal, the Wall Street Journal reported Sunday.
The newspaper said the squabbles could delay or derail antitrust approvals, though the deal does not appear to be in danger of imminent collapse. Sources familiar with the matter confirmed the citations in the Journal story.